The Valley Desk

NCT01435226 · Interventional trial

GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection

Overall registry status Completed

Phase 2

Conditions Hepatitis C, Chronic

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov